Schrodinger Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Schrodinger Inc 公司

Schrodinger, Inc. 運營一個基於物理的計算平臺，該平臺能夠發現用於藥物開發和材料應用的分子。該軟件平臺被世界各地的生物製藥和工業公司、學術機構和政府實驗室使用。該公司通過兩個部門運營：軟件和藥物發現。軟件部門專注於銷售其軟件，以改變整個生命科學行業以及材料科學行業的藥物發現。藥物發現部門專注於通過內部和合作建立多樣化的臨牀前和臨牀項目組合，這些項目已進入發現和開發的各個階段。該公司的藥物發現項目包括 SGR-1505（MALT1 抑制劑）、SGR-2921（CDC7 抑制劑）、SGR-3515（WEE1 抑制劑）。其軟件被全球 1,760 多家學術機構的研究人員使用。

公司簡介

公司代碼SDGR

公司名稱Schrodinger Inc

上市日期Feb 06, 2020

CEODr. Ramy Farid, Ph.D.

員工數量891

證券類型Ordinary Share

年結日Feb 06

公司地址1540 Broadway

城市NEW YORK

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編10036

電話15032991150

網址https://www.schrodinger.com

公司代碼SDGR

上市日期Feb 06, 2020

CEODr. Ramy Farid, Ph.D.

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Richard A. Friesner, Ph.D.

Director

1.24M

+0.49%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

36.99K

-30.96%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

25.97K

+92.81%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

23.64K

+112.26%

Mr. Arun Oberoi

Independent Director

12.25K

+95.95%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

12.25K

+95.95%

Michael M. Lynton ,

Independent Chairman of the Board

12.25K

+95.95%

Ms. Bridget Anne Van Kralingen

Independent Director

11.50K

+14.99%

Mannix Aklian

Executive Vice President, Chief Commercial Officer, Global Head of Software Sales & Marketing

--

Mr. Gary Ginsberg, J.D.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Richard A. Friesner, Ph.D.

Director

1.24M

+0.49%

Mr. Kenneth Patrick (Patrick) Lorton

Executive Vice President, Chief Operating Officer - Software

36.99K

-30.96%

Ms. Margaret Dugan, M.D.

Chief Medical Officer

25.97K

+92.81%

Ms. Yvonne Tran, J.D.

Chief People Officer, Executive Vice President, Chief Legal Officer

23.64K

+112.26%

Mr. Arun Oberoi

Independent Director

12.25K

+95.95%

Dr. Rosana Kapeller-Libermann, M.D., Ph.D.

Independent Director

12.25K

+95.95%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

On-premise software

25.42M

42.69%

Hosted software

10.87M

18.26%

Drug discovery services

10.24M

17.19%

Software maintenance

6.80M

11.41%

Contribution

3.84M

6.45%

Other

2.38M

4.00%

地區USD

名稱

營收

佔比

United States

29.66M

49.81%

EMEA

23.08M

38.76%

APAC

6.07M

10.20%

Rest of World

731.00K

1.23%

業務

地區

業務USD

名稱

營收

佔比

On-premise software

25.42M

42.69%

Hosted software

10.87M

18.26%

Drug discovery services

10.24M

17.19%

Software maintenance

6.80M

11.41%

Contribution

3.84M

6.45%

Other

2.38M

4.00%

股東統計

更新時間: 5月23日週五

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.07%

Bill & Melinda Gates Foundation Trust

10.87%

The Vanguard Group, Inc.

10.17%

Rubric Capital Management LP

7.48%

Nikko Asset Management Co., Ltd.

5.68%

Other

53.73%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.07%

Bill & Melinda Gates Foundation Trust

10.87%

The Vanguard Group, Inc.

10.17%

Rubric Capital Management LP

7.48%

Nikko Asset Management Co., Ltd.

5.68%

Other

53.73%

股東類型

持股股東

佔比

Investment Advisor

48.38%

Investment Advisor/Hedge Fund

25.00%

Hedge Fund

13.63%

Endowment Fund

10.87%

Individual Investor

2.65%

Research Firm

2.22%

Pension Fund

0.80%

Bank and Trust

0.49%

Venture Capital

0.13%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

570

67.20M

104.65%

-5.08M

2025Q1

593

67.21M

104.69%

-5.43M

2024Q4

576

64.44M

100.89%

-9.04M

2024Q3

581

67.44M

105.91%

-6.15M

2024Q2

573

64.76M

101.80%

-8.12M

2024Q1

574

63.48M

100.05%

-5.40M

2023Q4

584

62.06M

98.56%

-7.64M

2023Q3

586

63.62M

101.35%

-15.42M

2023Q2

584

64.04M

102.20%

-7.30M

2023Q1

543

57.09M

91.59%

-11.19M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.75M

12.07%

-354.21K

-4.37%

Mar 31, 2025

Bill & Melinda Gates Foundation Trust

6.98M

10.87%

--

Mar 31, 2025

The Vanguard Group, Inc.

6.53M

10.17%

-72.09K

-1.09%

Mar 31, 2025

Rubric Capital Management LP

4.80M

7.48%

-200.00K

-4.00%

Mar 31, 2025

Nikko Asset Management Co., Ltd.

3.46M

5.39%

-48.10K

-1.37%

Mar 31, 2025

UBS Asset Management (Switzerland)

2.47M

3.85%

+919.38K

+59.31%

Mar 31, 2025

Stephens Investment Management Group, LLC

1.97M

3.07%

+362.29K

+22.53%

Mar 31, 2025

State Street Global Advisors (US)

2.21M

3.44%

-104.66K

-4.52%

Mar 31, 2025

MFS Investment Management

2.09M

3.26%

-186.23K

-8.17%

Mar 31, 2025

ARK Investment Management LLC

2.29M

3.57%

+85.76K

+3.88%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

ARK Genomic Revolution ETF

3.78%

TrueShares Technology, AI & Deep Learning ETF

2.24%

Global X HealthTech ETF

1.25%

SPDR FactSet Innovative Technology ETF

0.97%

WisdomTree BioRevolution Fund

0.84%

Franklin Exponential Data ETF

0.81%

Invesco S&P SmallCap Health Care ETF

0.8%

Franklin Genomic Advancements ETF

0.63%

First Trust Multi-Manager Small Cap Opportunities ETF

0.46%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.44%

ARK Genomic Revolution ETF

佔比3.78%

TrueShares Technology, AI & Deep Learning ETF

佔比2.24%

Global X HealthTech ETF

佔比1.25%

SPDR FactSet Innovative Technology ETF

佔比0.97%

WisdomTree BioRevolution Fund

佔比0.84%

Franklin Exponential Data ETF

佔比0.81%

Invesco S&P SmallCap Health Care ETF

佔比0.8%

Franklin Genomic Advancements ETF

佔比0.63%

First Trust Multi-Manager Small Cap Opportunities ETF

佔比0.46%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比0.44%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Schrodinger Inc

19.872USD

Schrodinger Inc

19.872

概覽

公司

財務